Accelerate therapy development with real-world multi-modal data to uncover new insights across the research and development spectrum to make smarter decisions and launch molecules more efficiently.
Arrant's establishment is geared towards aggregating longitudinal clinical, genomics and proteomics data at Scale and Speed.
Leverage real-world multimodal data and bioinformatics expertise to identify disease subtypes and power discovery approaches to lead to novel therapeutic opportunities
Collaborate to advance the appropriate use of real-world evidence in oncology product development & to facilitate patient-centered regulatory decision-making.
To design trials, validate biomarker strategies, define optimal populations to study and assess execution feasibility. Plus, conduct trial simulation and survival analysis to support trial success
Analyze your target of interest and identify the most appropriate patient population to evaluate for your therapy program
Arrant establishes joint research teams combining disciplines from computational biology, medical, bioinformatics, and machine learning to work alongside your teams with a goal of accelerating therapy development.